ML DOCTORS LIMITED Filleted accounts for Companies House (small and micro)

ML DOCTORS LIMITED - Company Information

3 false false false false false false false false false false true false false false false false false No description of principal activity 2022-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 534,642 534,642 534,642 xbrli:pure xbrli:shares iso4217:GBP 06848520 2022-04-01 2023-03-31 06848520 2023-03-31 06848520 2022-03-31 06848520 2021-04-01 2022-03-31 06848520 2022-03-31 06848520 2021-03-31 06848520 core:PlantMachinery 2022-04-01 2023-03-31 06848520 core:FurnitureFittings 2022-04-01 2023-03-31 06848520 bus:Director3 2022-04-01 2023-03-31 06848520 bus:Director1 2022-04-01 2023-03-31 06848520 core:PlantMachinery 2022-03-31 06848520 core:FurnitureFittings 2022-03-31 06848520 core:LandBuildings 2023-03-31 06848520 core:PlantMachinery 2023-03-31 06848520 core:FurnitureFittings 2023-03-31 06848520 core:WithinOneYear 2023-03-31 06848520 core:WithinOneYear 2022-03-31 06848520 core:AfterOneYear 2023-03-31 06848520 core:AfterOneYear 2022-03-31 06848520 core:ShareCapital 2023-03-31 06848520 core:ShareCapital 2022-03-31 06848520 core:RetainedEarningsAccumulatedLosses 2023-03-31 06848520 core:RetainedEarningsAccumulatedLosses 2022-03-31 06848520 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 06848520 core:Non-currentFinancialInstruments 2023-03-31 06848520 core:Non-currentFinancialInstruments 2022-03-31 06848520 core:LandBuildings 2022-03-31 06848520 core:PlantMachinery 2022-03-31 06848520 core:FurnitureFittings 2022-03-31 06848520 bus:Director1 2022-03-31 06848520 bus:Director1 2023-03-31 06848520 bus:Director1 2021-03-31 06848520 bus:Director1 2022-03-31 06848520 bus:Director1 2021-04-01 2022-03-31 06848520 bus:SmallEntities 2022-04-01 2023-03-31 06848520 bus:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 06848520 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 06848520 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 06848520 bus:FullAccounts 2022-04-01 2023-03-31

COMPANY REGISTRATION NUMBER: 06848520

ML DOCTORS LIMITED

Filleted Unaudited Financial Statements

31 March 2023

ML DOCTORS LIMITED

Statement of Financial Position

31 March 2023

	2023		2022
Note	£	£	£

Fixed assets

Tangible assets	5	299,319	315,200
Investments	6	534,642	534,642
		---------	---------
		833,961	849,842

Current assets

Stocks		350,150	395,265
Debtors	7	184,688	249,814
Cash at bank and in hand		24,631	251,792
		---------	---------
		559,469	896,871

Creditors: amounts falling due within one year	8	661,079		918,020
		---------		---------
Net current liabilities			101,610	21,149
			---------	---------
Total assets less current liabilities			732,351	828,693

Creditors: amounts falling due after more than one year	9		86,734	103,480

Provisions

Taxation including deferred tax	2,941	2,941
	---------	---------
Net assets	642,676	722,272
	---------	---------

Capital and reserves

Called up share capital	2	2
Profit and loss account	642,674	722,270
	---------	---------
Shareholders funds	642,676	722,272
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

ML DOCTORS LIMITED

Statement of Financial Position (continued)

31 March 2023

These financial statements were approved by the board of directors and authorised for issue on 30 March 2024 , and are signed on behalf of the board by:

M R Zia
Director

Company registration number: 06848520

ML DOCTORS LIMITED

Notes to the Financial Statements

Year ended 31 March 2023

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ml House, 9 North Street, Manchester, M8 8RE.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Plant and machinery	-	20% reducing balance
Fixtures and fittings	-	10% reducing balance
Equipment	-	10% reducing balance
R & D	-	25% straight line

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Government grants

Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 3 (2022: 4 ).

5. Tangible assets

	Land and buildings	Plant and machinery	Fixtures and fittings	Equipment	User defined asset	Total
	£	£	£	£	£	£
Cost
At 1 Apr 2022 and 31 Mar 2023	164,356	67,839	76,575	47,461	120,516	476,747
	---------	--------	--------	--------	---------	---------
Depreciation
At 1 Apr 2022	–	59,856	37,681	15,971	48,039	161,547
Charge for the year	–	1,596	3,889	3,149	7,247	15,881
	---------	--------	--------	--------	---------	---------
At 31 Mar 2023	–	61,452	41,570	19,120	55,286	177,428
	---------	--------	--------	--------	---------	---------
Carrying amount
At 31 Mar 2023	164,356	6,387	35,005	28,341	65,230	299,319
	---------	--------	--------	--------	---------	---------
At 31 Mar 2022	164,356	7,983	38,894	31,490	72,477	315,200
	---------	--------	--------	--------	---------	---------

6. Investments

	Other investments other than loans
	£
Cost
At 1 April 2022 and 31 March 2023	534,642
	---------
Impairment
At 1 April 2022 and 31 March 2023	–
	---------

Carrying amount
At 31 March 2023	534,642
	---------
At 31 March 2022	534,642
	---------

7. Debtors

	2023	2022
	£	£
Trade debtors	184,688	249,814
	---------	---------

8. Creditors: amounts falling due within one year

	2023	2022
	£	£
Bank loans and overdrafts	13,361	3,400
Trade creditors	416,231	636,690
Corporation tax	16,609	65,109
Social security and other taxes	132,663	131,246
Other creditors	82,215	81,575
	---------	---------
	661,079	918,020
	---------	---------

9. Creditors: amounts falling due after more than one year

	2023	2022
	£	£
Bank loans and overdrafts	86,734	103,480
	--------	---------

10. Director's advances, credits and guarantees

During the year the director entered into the following advances and credits with the company:

	2023
	Balance brought forward	Advances/ (credits) to the director	Balance outstanding
	£	£	£
Muhammad Ahmad	( 35,187)	2,000	( 33,187)
	--------	-------	--------

	2022
	Balance brought forward	Advances/ (credits) to the director	Balance outstanding
	£	£	£
Muhammad Ahmad	( 8,687)	( 26,500)	( 35,187)
	-------	--------	--------